fbpx

Stay Informed. Stay Competitive. Get Free Email Updates Dow 30 & Emerging Growth

Stay Informed. Stay Competitive.

Get Free Updates

Dow 30 & Emerging Growth

Join Today’s Tribe Public FREE Webinar “A Town Hall Q&A Event With Atossa Therapeutics Management Team”

By John F. Heerdink, Jr.

Please join our sister organization, which is hosting a Tribe Public  FREE Q&A Webinar Event today, Tuesday, November 30 (8 am PT/ 11 am ET). The events are approximately 30 minutes in duration. Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. The Tribe’s complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness and understanding of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, & Accredited Investors are afforded the direct corporate access to the leaders of NYSE and NASDAQ companies regularly. Website: http://www.tribepublic.com/.



Today’s event will host Steven Quay, MD, PhD, CEO & Founder & Kyle Guse, CFO of Atossa Therapeutics (NASDAQ: ATOS)  an event titled “A Town Hall Q&A Event With Atossa Therapeutics Management Team” where they will address a series of questions relayed by Tribe management. Please register at ATOSAQ.TribePublic.com. After doing so, please consider sending your questions for management prior to event to research@tribepublic.com or during the event via the ZOOM chat feature.

Atossa Therapeutics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19. Website: www.atossatherapeutics.com.

Dr. Quay is an author, entrepreneur, and accomplished physician-scientist that has founded six startups invented seven FDA-approved pharmaceuticals and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. He received his M.D., M.A., and Ph.D. from The University of Michigan. He was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana and a resident at the Harvard-Massachusetts General Hospital. He was on the faculty of Stanford University School of Medicine for almost a decade. Website: www.DrQuay.com.



YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us